Integra Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Integra LifeSciences Holdings
IART Stock  USD 12.19  0.18  1.50%   
Analyzing historical trends in various income statement and balance sheet accounts from Integra LifeSciences' financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Integra LifeSciences' valuation are summarized below:
Gross Profit
944.7 M
Profit Margin
(0.30)
Market Capitalization
949.7 M
Enterprise Value Revenue
1.6358
Revenue
1.6 B
There are currently one hundred twenty fundamental trends for Integra LifeSciences that can be evaluated and compared over time across competitors. All traders should confirm Integra LifeSciences' regular fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 1 B in 2026. Enterprise Value is likely to gain to about 442.9 M in 2026

Integra LifeSciences Total Revenue

1.94 Billion

Check Integra LifeSciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Integra LifeSciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 169.7 M, Interest Expense of 85.3 M or Total Revenue of 1.9 B, as well as many indicators such as Price To Sales Ratio of 1.18, Dividend Yield of 3.0E-4 or PTB Ratio of 1.23. Integra financial statements analysis is a perfect complement when working with Integra LifeSciences Valuation or Volatility modules.
  
Build AI portfolio with Integra Stock
Check out the analysis of Integra LifeSciences Correlation against competitors.

Integra LifeSciences Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets4.9 B4.6 B2.8 B
Slightly volatile
Other Current Liabilities250.6 M238.7 M137.4 M
Slightly volatile
Total Current Liabilities1.1 B1.1 B360.4 M
Slightly volatile
Total Stockholder Equity1.9 B1.8 B1.1 B
Slightly volatile
Property Plant And Equipment Net663.8 M632.2 M336.9 M
Slightly volatile
Accounts Payable99.6 M94.9 M63.8 M
Slightly volatile
Cash297.5 M283.3 M211.9 M
Slightly volatile
Non Current Assets Total3.6 B3.4 B2 B
Slightly volatile
Cash And Short Term Investments330.3 M314.6 M219.2 M
Slightly volatile
Net Receivables328.9 M313.2 M203.1 M
Slightly volatile
Common Stock Shares Outstanding67.8 M88.6 M72.4 M
Slightly volatile
Liabilities And Stockholders Equity4.9 B4.6 B2.8 B
Slightly volatile
Non Current Liabilities Total1.9 B1.8 B1.3 B
Slightly volatile
Inventory518.1 M493.5 M288.2 M
Slightly volatile
Other Current Assets66.4 M122.7 M91.6 M
Slightly volatile
Other Stockholder Equity475 M726.8 M647.6 M
Slightly volatile
Total Liabilities3 B2.9 B1.6 B
Slightly volatile
Property Plant And Equipment Gross1.1 B1.1 B474.8 M
Slightly volatile
Total Current Assets1.3 B1.2 B800 M
Slightly volatile
Intangible Assets1.5 B1.4 B819.2 M
Slightly volatile
Short and Long Term Debt Total2.4 B2.3 B1.3 B
Slightly volatile
Common Stock Total Equity528.7 K1 M684.8 K
Slightly volatile
Short Term Debt750.6 M714.9 M191.8 M
Slightly volatile
Common Stock565.2 K1.1 M688.6 K
Slightly volatile
Other Liabilities243.7 M232.1 M126.3 M
Slightly volatile
Other Assets69 M72.6 M265.1 M
Pretty Stable
Long Term Debt774.3 M1.4 B974 M
Slightly volatile
Property Plant Equipment375.9 M358 M254.9 M
Slightly volatile
Current Deferred Revenue12.7 M12.1 M6.6 M
Slightly volatile
Good Will1.3 B1.3 B752.8 M
Slightly volatile
Retained Earnings Total Equity1.1 B1 B513.8 M
Slightly volatile
Long Term Debt Total1 B1.5 B1 B
Slightly volatile
Capital Surpluse1 B1.5 B1 B
Slightly volatile
Non Current Liabilities Other151 M168.2 M139.9 M
Slightly volatile
Deferred Long Term Asset Charges8.1 M6.2 M9 M
Slightly volatile
Short and Long Term Debt733 M698.1 M183.1 M
Slightly volatile
Long Term Investments3.5 M6.2 M3.6 M
Slightly volatile
Net Invested Capital3.3 B3.9 B3 B
Slightly volatile
Net Working Capital136.4 M143.6 M500.4 M
Pretty Stable
Capital Stock987.8 K1.1 M904 K
Slightly volatile
Capital Lease Obligations156.1 M208.7 M129.6 M
Slightly volatile

Integra LifeSciences Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization169.7 M161.6 M85.4 M
Slightly volatile
Total Revenue1.9 B1.9 B1.2 B
Slightly volatile
Gross Profit1.1 B1 B735.3 M
Slightly volatile
Other Operating Expenses1.9 B1.8 B1.1 B
Slightly volatile
Research Development139.3 M132.7 M76.7 M
Slightly volatile
Cost Of Revenue879.6 M837.7 M491.8 M
Slightly volatile
Total Operating Expenses1 B981.7 M648.8 M
Slightly volatile
Selling General Administrative865.8 M824.5 M551 M
Slightly volatile
Non Recurring61.4 M74.7 M61 M
Slightly volatile
Interest Income24.2 M23 M15.7 M
Pretty Stable
Reconciled Depreciation113.4 M162 M101.3 M
Slightly volatile

Integra LifeSciences Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow333.8 M317.9 M209 M
Slightly volatile
Depreciation170.1 M162 M94.3 M
Slightly volatile
Capital Expenditures126.1 M120.1 M65.5 M
Slightly volatile
End Period Cash Flow297.5 M283.3 M211.8 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.181.253.0143
Slightly volatile
Dividend Yield3.0E-43.0E-43.0E-4
Slightly volatile
PTB Ratio1.231.32.8903
Slightly volatile
Days Sales Outstanding68.8970.9960.697
Slightly volatile
Book Value Per Share18.9618.0614.4458
Slightly volatile
Capex To Depreciation1.050.850.8254
Slightly volatile
PB Ratio1.231.32.8903
Slightly volatile
EV To Sales4.492.493.8867
Pretty Stable
Inventory Turnover1.941.951.7778
Very volatile
Days Of Inventory On Hand170194211
Slightly volatile
Payables Turnover10.6210.158.7177
Pretty Stable
Sales General And Administrative To Revenue0.570.540.4966
Pretty Stable
Research And Ddevelopement To Revenue0.130.08240.092
Slightly volatile
Capex To Revenue0.07290.07460.0675
Slightly volatile
Cash Per Share3.363.22.7342
Slightly volatile
Days Payables Outstanding32.1837.245.2668
Pretty Stable
Intangibles To Total Assets0.340.510.5057
Slightly volatile
Net Debt To EBITDA8.58.095.2475
Slightly volatile
Current Ratio1.281.353.2263
Slightly volatile
Receivables Turnover4.745.326.0779
Slightly volatile
Shareholders Equity Per Share18.9618.0614.4458
Slightly volatile
Debt To Equity0.711.160.9819
Slightly volatile
Capex Per Share1.281.220.8429
Slightly volatile
Revenue Per Share19.7618.8215.7088
Slightly volatile
Interest Debt Per Share25.2224.0216.1515
Slightly volatile
Debt To Assets0.30.440.4119
Slightly volatile
Graham Number11.1117.9116.9052
Slightly volatile
Short Term Coverage Ratios0.180.197.7074
Slightly volatile
Operating Cycle219249267
Pretty Stable
Price Book Value Ratio1.231.32.8903
Slightly volatile
Days Of Payables Outstanding32.1837.245.2668
Pretty Stable
Company Equity Multiplier1.592.352.2279
Pretty Stable
Long Term Debt To Capitalization0.320.390.4465
Very volatile
Total Debt To Capitalization0.350.510.4758
Slightly volatile
Debt Equity Ratio0.711.160.9819
Slightly volatile
Quick Ratio0.770.812.0859
Slightly volatile
Cash Ratio0.290.310.8619
Slightly volatile
Cash Conversion Cycle257271229
Slightly volatile
Days Of Inventory Outstanding170194211
Slightly volatile
Days Of Sales Outstanding68.8970.9960.697
Slightly volatile
Cash Flow Coverage Ratios0.07120.0750.1333
Slightly volatile
Price To Book Ratio1.231.32.8903
Slightly volatile
Fixed Asset Turnover5.953.374.0115
Very volatile
Debt Ratio0.30.440.4119
Slightly volatile
Cash Flow To Debt Ratio0.07120.0750.1333
Slightly volatile
Price Sales Ratio1.181.253.0143
Slightly volatile
Asset Turnover0.580.460.5054
Slightly volatile
Gross Profit Margin0.670.630.6202
Pretty Stable
Price Fair Value1.231.32.8903
Slightly volatile

Integra LifeSciences Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1 B963.6 M1 B
Slightly volatile
Enterprise Value442.9 M421.8 M443.8 M
Slightly volatile

Integra Fundamental Market Drivers

Forward Price Earnings5.2083
Cash And Short Term Investments273.6 M

Integra Upcoming Events

28th of February 2024
Upcoming Quarterly Report
View
24th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Integra LifeSciences Financial Statements

Integra LifeSciences shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Integra LifeSciences investors may analyze each financial statement separately, they are all interrelated. The changes in Integra LifeSciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Integra LifeSciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue12.1 M12.7 M
Total Revenue1.9 B1.9 B
Cost Of Revenue837.7 M879.6 M
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.54  0.57 
Research And Ddevelopement To Revenue 0.08  0.13 
Capex To Revenue 0.07  0.07 
Revenue Per Share 18.82  19.76 
Ebit Per Revenue 0.02  0.02 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Integra Stock Analysis

When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY